Explore our new Supplier Directory

Aarti Drugs Ltd (ADL) is a part of the Aarti Group of Industries, which has a total worth of USD 500 million. It was established in 1984 and has since developed a strong presence in the fields of Anti-diarrhea and Anti-inflammatory therapeutic groups. The company's manufacturing facilities are located in Tarapur and Sarigam, where it produces a variety of medicines including Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, anti-diabetic, anti-cholinergic, sedatives, and anti-depressant drugs. Over the years, ADL has successfully carved a niche for itself and is now planning to increase its production capacity.

Amoli has been working collaboratively with some of the leading global healthcare players since 3 decades. Our strength comes from our expertise in process chemistry further bolstered by our EDQM and USFDA approved facilities allowing us to cater to the needs of the pharmaceutical industry globally. We offer APIs from a wide range of therapeutic classes like NSAIDS, Antifungals, Antidepressants, Hypolipidemics etc. With the support our state-of-the-art R&D centre, we are constantly expanding our product range and foraying into newer therapeutic categories.

CordenPharma International, an all-encompassing CDMO for the worldwide market. Established as the global pharmaceutical service & production platform of International Chemical Investors Group in 2006, CordenPharma serves as your all-encompassing ally in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products, and associated Packaging Services. With an expanding network of cGMP facilities throughout Europe and the US structured under five Technology Platforms – Peptides, Lipids & Carbohydrates - Highly Potent & Oncology - Injectables - Small Molecules - Antibiotics – CordenPharma specialists interpret intricate processes, concepts and ventures at any phase.

USV is a 60-year-old organization headquartered in Mumbai, generating approximately US$ 500 million in revenue, primarily from the Diabetic and Cardiac sectors. It is one of the top 15 companies in India, operating in over 60 countries and serving more than 100 satisfied customers with exports totaling around US$ 100 million. With 100+ product approvals globally and 30+ DMF submissions worldwide, USV provides value-added products in Oral Solids, Injectables (PFS, Vials), Ophthalmics, Biosimilars (Pegfilgrastim), and Peptides.

COSMA S. P. A. (established in 1977) and AMSA S. P. A. (established in 1953) are a pair of chemical facilities widely recognized globally and particularly valued in the occidental world and in the nations that adhere to the Pharmaceutical Inspection Convention (PIC). They are part of the CFM Group, a privately-owned company engaged in the fields of chemistry and pharmaceuticals since 1949

Vaishali Pharma Ltd is an esteemed and rapidly expanding company with a 30-year history in the Pharmaceutical & Healthcare Industry. It serves as a comprehensive solution center for all healthcare needs. VPL operates in 9 different sectors of the pharmaceutical market, exporting to over 25 countries. It has received credit rating certification from NSIC CRISIL and ISO 9001:2008 certification for Quality Management from BM Trada UKAS. VPL has been honored with the 'Most Prestigious Brand in Asia 2018-19' award by BARC and is recognized as a One Star Export House. Additionally, it boasts a workforce of 150 employees.

Biesterfeld Spezialchemie stands as a prominent global distributor of specialty chemical products, pharmaceuticals, and food ingredients. The organization provides comprehensive industry expertise and custom, application-oriented technical guidance across a varied product range focusing on the needs of specific sectors, such as composites and tooling, personal care and hygiene, healthcare, paints and coatings, adhesives, polyurethane, construction, nutrition, nutraceuticals, and electrical, electronic, and energy.

Nortec Química is the largest manufacturer of Active Pharmaceutical Ingredients (APIs) in Latin America and began its activities determined to guarantee quality medicines with APIs developed in Brazil. To this end, the company combined the knowledge of the main National Research Centers with the experience of the Brazilian Chemical and Petrochemical Industry. Nortec Química is very important in the Brazilian pharmaceutical scenario and in the Unified Health System (SUS), producing APIs for branded, generic and similar drugs and drugs for neglected diseases.

Yung Zip is an international professional bulk drug manufacturing company with customers distributed all over the world. In addition to supplying APIs, API intermediates and specialty chemicals, it also provides CRO and CMO services to customers both domestic and international. Yung Zip assists its customers with full suite support with chemical, manufacturing and control support for GMP-compliant API and drug manufacturing and registration over all stages of development.

Established in 1977 and initially reviewed by the FDA in 1984, COSMA SpA stands as the primary facility within the group, specializing in high-volume APIs with a reaction volume surpassing 130 m3. A modern, cutting-edge expansion of production capabilities was completed in 2011 and 2012.

Established in April 1992, SAMO' was founded with the primary goal of advancing the pharmaceutical sector across all nations during the era of independence. Consequently, the company has created 32 employment opportunities and has engaged local industry professionals. Presently, the organization collaborates with medical experts, professors, as well as members of the International Academy of Ecology and Life Safety, possessing dual PhDs and highly skilled personnel. The future of the pharmaceutical field greatly relies on the types and quantities of medications, along with their appropriateness for the population's needs.

Redox Bio Co., Ltd. specializes in the exploration and creation of sodium hyaluronate as the initial step in the biopharmaceutical sector. This bio-derived polymeric polysaccharide is widely utilized in pharmaceuticals like eye drops, joint lubricants, and arthritis treatments, as well as in medical devices such as wrinkle-improving fillers and anti-adhesion materials, owing to its distinctive safety, non-immunity, viscoelasticity, and biocompatibility.

We are Assertio — a dynamic, proactive, and compassionate pharmaceutical company centered on the goal of improving patient care. Previously recognized as Depomed, we have restructured our organization with a current emphasis on three FDA-approved products in our primary fields of neurology, orphan, and specialized medications, while continuously seeking out, licensing, and creating new products that provide improved choices for patients who may have limited access to existing treatments.